Product Information

ZOLMITRIPTAN 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.4179 per EA under NDC 16571080413. Its NADAC has been published 244 times since Dec 22, 2021.

FDA first approved this application on May 11, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZOLMITRIPTAN 5 MG TABLET

Zolmitriptan
$1.4179per EA

Strength

5 mg/1

NDC

16571080413

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ZOLMITRIPTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA207021

FDA Approved

5/11/2016

TE Code

AB

On Market Since

5/11/2016

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for ZOLMITRIPTAN 5 MG TABLET has been published 244 times since Dec 22, 2021, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4179 per EA
All-time high$2.1466 (Feb 16, 2022)
All-time low$1.1137 (May 22, 2024)
52-week high$1.5666
52-week low$1.2261
Median price$1.4729
Average price$1.4889
Largest weekly change+45.4% (Jan 19, 2022)
Weeks tracked244
Tracking sinceDec 22, 2021

Price History

1W

-1.7%

1M

-1.7%

3M

+1.7%

6M

-9.5%

1Y

-5.2%

3Y

+7.3%

5Y

N/A

All

-4.0%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZOLMITRIPTAN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $1.4179 per EA (NDC 16571080413), effective Aug 19, 2026.

How has the price of ZOLMITRIPTAN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG TABLET has declined 4.0%. It has been tracked across 244 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG TABLET?

Since Dec 22, 2021, the NADAC for ZOLMITRIPTAN 5 MG TABLET has ranged from a low of $1.1137 (May 22, 2024) to a high of $2.1466 (Feb 16, 2022), with a median of $1.4729 per EA.

Are there cheaper alternatives to ZOLMITRIPTAN 5 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZOLMITRIPTAN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZOLMITRIPTAN 5 MG TABLET?

ZOLMITRIPTAN 5 MG TABLET (NDC 16571080413) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.